Molecular biology and genetic diversity of Rift Valley fever virus

被引:100
作者
Ikegami, Tetsuro [1 ,2 ,3 ]
机构
[1] Univ Texas Med Branch, Dept Pathol, MMNP3-206D,301 Univ Blvd, Galveston, TX 77555 USA
[2] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA
[3] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA
关键词
Rift Valley fever virus; Bunyavirus; Phlebovirus; Genetic diversity; Phylogenetics; MEDIATED ISOTHERMAL AMPLIFICATION; POLYMERASE CHAIN-REACTION; RNA GENOME SEGMENTS; NSS PROTEIN; RAPID DETECTION; NONCODING REGIONS; SANDFLY FEVER; WILD-TYPE; IN-VIVO; TRANSCRIPTION;
D O I
10.1016/j.antiviral.2012.06.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Rift Valley fever virus (RVFV), a member of the family Bunyaviridae, genus Phlebovirus, is the causative agent of Rift Valley fever (RVF), a mosquito-borne disease of ruminant animals and humans. The generation of a large sequence database has facilitated studies of the evolution and spread of the virus. Bayesian analyses indicate that currently circulating strains of RVFV are descended from an ancestral species that emerged from a natural reservoir in Africa when large-scale cattle and sheep farming were introduced during the 19th century. Viruses descended from multiple lineages persist in that region, through infection of reservoir animals and vertical transmission in mosquitoes, emerging in years of heavy rainfall to cause epizootics and epidemics. On a number of occasions, viruses from these lineages have been transported outside the enzootic region through the movement of infected animals or mosquitoes, triggering outbreaks in countries such as Egypt, Saudi Arabia, Mauritania and Madagascar, where RVF had not previously been seen. Such viruses could potentially become established in their new environments through infection of wild and domestic ruminants and other animals and vertical transmission in local mosquito species. Despite their extensive geographic dispersion, all strains of RVFV remain closely related at the nucleotide and amino acid level. The high degree of conservation of genes encoding the virion surface glycoproteins suggests that a single vaccine should protect against all currently circulating RVFV strains. Similarly, preservation of the sequence of the RNA-dependent RNA polymerase across viral lineages implies that antiviral drugs targeting the enzyme should be effective against all strains. Researchers should be encouraged to collect additional RVFV isolates and perform whole-genome sequencing and phylogenetic analysis, so as to enhance our understanding of the continuing evolution of this important virus. This review forms part of a series of invited papers in Antiviral Research on the genetic diversity of emerging viruses. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:293 / 310
页数:18
相关论文
共 50 条
  • [31] Rift Valley fever virus infection : physiopathology and pathogenesis
    Quellec, Jordan
    Salinas, Sara
    Simonin, Yannick
    Cetre-Sossah, Catherine
    VIROLOGIE, 2021, 25 (05) : 263 - 279
  • [32] Mechanism of tripartite RNA genome packaging in Rift Valley fever virus
    Terasaki, Kaori
    Murakami, Shin
    Lokugamage, Kumari G.
    Makino, Shinji
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (02) : 804 - 809
  • [33] Rift Valley Fever Virus Encephalitis: Viral and Host Determinants of Pathogenesis
    Wilson, Lindsay R.
    McElroy, Anita K.
    ANNUAL REVIEW OF VIROLOGY, 2024, 11 : 309 - 325
  • [34] Observations on rift valley fever virus and vaccines in Egypt
    Samia Ahmed Kamal
    Virology Journal, 8
  • [35] Animal models of Rift Valley fever virus infection
    Ross, Ted M.
    Bhardwaj, Nitin
    Bissel, Stephanie J.
    Hartman, Amy L.
    Smith, Darci R.
    VIRUS RESEARCH, 2012, 163 (02) : 417 - 423
  • [36] Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins
    Hoai J. Ly
    Tetsuro Ikegami
    Virology Journal, 13
  • [37] Rift Valley fever
    Paweska, J. T.
    REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 2015, 34 (02): : 375 - 389
  • [38] Mechanistic insight into the efficient packaging of antigenomic S RNA into Rift Valley fever virus particles
    Tercero, Breanna
    Terasaki, Kaori
    Narayanan, Krishna
    Makino, Shinji
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [39] Pathogenesis of Rift Valley Fever Virus Aerosol Infection in STAT2 Knockout Hamsters
    Hickerson, Brady T.
    Westover, Jonna B.
    Van Wettere, Arnaud J.
    Rigas, Johanna D.
    Miao, Jinxin
    Conrad, Bettina L.
    Motter, Neil E.
    Wang, Zhongde
    Gowen, Brian B.
    VIRUSES-BASEL, 2018, 10 (11):
  • [40] Novel approaches to develop Rift Valley fever vaccines
    Indran, Sabarish V.
    Ikegami, Tetsuro
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2012, 2 : 131